They also have the potential to make a profound impact on broader lifestyle choices, such as alcohol and tobacco consumption
The most recent study from France titled GLP-1 receptor agonists and the risk of thyroid cancer (2) concluded that there was, in fact, an increased risk of all thyroid cancer and medullary thyroid cancer with the use of GLP-1 receptor agonists, in particular after 1-3 years of treatment
People are getting surgery for 'Ozempic ears' after taking after GLP-1 weight loss medication, as an expert has warned that many people don't consider the long-term effects
As such, more employers are looking to offer healthcare plans that include these medications
For intention-to-treat analysis, follow-up started at treatment assignment (T0) and ended at the occurrence of outcomes, death or last encounter (to 30 June 2024)
Kidney Problems Byetta and Bydureon may also result in significant kidney problems over time